|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.40 EUR | -0.80% |
|
-3.77% | +35.55% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,062B | |||||
| 619B | - | - | - | ||
| 431B | |||||
| 358B | |||||
| 293B |
- Stock Market
- Stocks
- IPN Stock
- 0MH6 Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
